Louis-Armstrong

Ionis announces third investigational antisense medicine to treat nonalcoholic steatohepatitis (NASH) enters development

CARLSBAD, Calif., Nov. 23, 2020 /PRNewswire/ —¬†Ionis Pharmaceuticals, Inc. (NASDAQ: IONS)¬†announced today that the biopharmaceutical company…